BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan. Cancer Med 2019;8:3992-4000. [PMID: 31119891 DOI: 10.1002/cam4.2277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma ZH, Shuai Y, Gao XY, Yan Y, Wang KM, Wen XZ, Ji JF. BTEB2-Activated lncRNA TSPEAR-AS2 Drives GC Progression through Suppressing GJA1 Expression and Upregulating CLDN4 Expression. Mol Ther Nucleic Acids 2020;22:1129-41. [PMID: 33294297 DOI: 10.1016/j.omtn.2020.10.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu J, Zheng F, Yang M, Wu X, Liu A. Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis. Medicine (Baltimore) 2021;100:e26870. [PMID: 34414938 DOI: 10.1097/MD.0000000000026870] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Reference Citation Analysis]
4 Huang Y, Zhang H, Gu X, Qin S, Zheng M, Shi X, Peng C, Ju S. Elucidating the Role of Serum tRF-31-U5YKFN8DYDZDD as a Novel Diagnostic Biomarker in Gastric Cancer (GC). Front Oncol 2021;11:723753. [PMID: 34497770 DOI: 10.3389/fonc.2021.723753] [Reference Citation Analysis]
5 Choi Y, Kim N, Yun CY, Choi YJ, Yoon H, Shin CM, Park YS, Ahn SH, Joong Park D, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Lee DH, Kim HH. Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years. Gastric Cancer 2020;23:1051-63. [PMID: 32361784 DOI: 10.1007/s10120-020-01076-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan. Cancer Med 2019;8:3992-4000. [PMID: 31119891 DOI: 10.1002/cam4.2277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Park CH. Helicobacter pylori Eradication and Gastric Cancer Prevention. Korean J Helicobacter Up Gastrointest Res 2021;21:267-74. [DOI: 10.7704/kjhugr.2021.0044] [Reference Citation Analysis]
8 Janati A, Khodayari-Zarnaq R, Khanijahani A, Khoshbaten M, Ghamkhar A, Kabiri N. Adherence to the new policy framework of the World Cancer Research Fund International in developing a policy package for the prevention of gastrointestinal cancers in Iran: a Delphi study. Glob Health Action 2021;14:1978661. [PMID: 34586047 DOI: 10.1080/16549716.2021.1978661] [Reference Citation Analysis]
9 Kumar S, Metz DC, Ginsberg GG, Kaplan DE, Goldberg DS. Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection. Aliment Pharmacol Ther 2020;51:781-8. [PMID: 32133681 DOI: 10.1111/apt.15677] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
10 Grover K, Gregory S, Gibbs JF, Emenaker NJ. A discussion of the gut microbiome's development, determinants, and dysbiosis in cancers of the esophagus and stomach. J Gastrointest Oncol 2021;12:S290-300. [PMID: 34422393 DOI: 10.21037/jgo-2019-gi-07] [Reference Citation Analysis]
11 Xu D, Liu R, Xu H, Zhang Z, Li W, Zhang Y, Zhang W, Hussein AF. Adoption of Two-Dimensional Ultrasound Gastrointestinal Filling Contrast on Artificial Intelligence Algorithm in Clinical Diagnosis of Gastric Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/7385344] [Reference Citation Analysis]
12 Kong S, Tian S, Wang Z, Shi Y, Zhang J, Zhuo H. Circular RNA circPFKP suppresses the proliferation and metastasis of gastric cancer cell via sponging miR-644 and regulating ADAMTSL5 expression. Bioengineered 2022;13:12326-37. [PMID: 35587154 DOI: 10.1080/21655979.2022.2073001] [Reference Citation Analysis]
13 Yokota K, Osaki T, Hayashi S, Yokota SI, Takeuchi H, Rimbara E, Ojima H, Sato T, Yonezawa H, Shibayama K, Tokunaga K, Kamiya S, Murakami K, Kato M, Sugiyama T. Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing. Helicobacter 2022;:e12874. [PMID: 35255160 DOI: 10.1111/hel.12874] [Reference Citation Analysis]